JP2023542107A5 - - Google Patents
Info
- Publication number
- JP2023542107A5 JP2023542107A5 JP2023516720A JP2023516720A JP2023542107A5 JP 2023542107 A5 JP2023542107 A5 JP 2023542107A5 JP 2023516720 A JP2023516720 A JP 2023516720A JP 2023516720 A JP2023516720 A JP 2023516720A JP 2023542107 A5 JP2023542107 A5 JP 2023542107A5
- Authority
- JP
- Japan
- Prior art keywords
- containing seq
- antibody
- cdr3
- coronavirus
- cdr1
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2014453.1 | 2020-09-14 | ||
| GBGB2014451.5A GB202014451D0 (en) | 2020-09-14 | 2020-09-14 | Single domain antibodies |
| GB2014451.5 | 2020-09-14 | ||
| GBGB2014453.1A GB202014453D0 (en) | 2020-09-14 | 2020-09-14 | Linker |
| GBGB2108319.1A GB202108319D0 (en) | 2021-06-10 | 2021-06-10 | Single domain antibodies |
| GB2108319.1 | 2021-06-10 | ||
| PCT/GB2021/052383 WO2022053839A1 (en) | 2020-09-14 | 2021-09-14 | Single domain antibodies that target sars-cov-2 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023542107A JP2023542107A (ja) | 2023-10-05 |
| JP2023542107A5 true JP2023542107A5 (https=) | 2024-09-25 |
Family
ID=77951755
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023516720A Withdrawn JP2023542107A (ja) | 2020-09-14 | 2021-09-14 | ＳＡＲＳ－ＣｏＶ－２を標的とするシングルドメイン抗体 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230374116A1 (https=) |
| EP (1) | EP4211157A1 (https=) |
| JP (1) | JP2023542107A (https=) |
| KR (1) | KR20240102916A (https=) |
| AU (1) | AU2021339978A1 (https=) |
| CA (1) | CA3192456A1 (https=) |
| WO (1) | WO2022053839A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116813759B (zh) * | 2022-03-21 | 2025-11-28 | 中国科学院微生物研究所 | 纳米抗体r14的构建体及其应用 |
| CN114736293B (zh) * | 2022-06-14 | 2022-09-02 | 中国农业科学院生物技术研究所 | SARS-CoV-2中和性纳米抗体、自组装铁蛋白融合纳米抗体及制备方法和应用 |
| CN117603358B (zh) * | 2023-02-24 | 2024-11-01 | 中国科学院微生物研究所 | 一种广谱新型冠状病毒的双特异性抗体 |
| CN118255878A (zh) * | 2024-04-15 | 2024-06-28 | 深圳细胞谷生物医药有限公司 | SARS-CoV-2驼源纳米抗体或其抗原结合片段、及其组合物和应用 |
| GB202413879D0 (en) | 2024-09-20 | 2024-11-06 | Rosalind Franklin Inst | Single domain antibodies |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101911438B1 (ko) * | 2012-10-31 | 2018-10-24 | 삼성전자주식회사 | 이중 특이 항원 결합 단백질 복합체 및 이중 특이 항체의 제조 방법 |
-
2021
- 2021-09-14 CA CA3192456A patent/CA3192456A1/en active Pending
- 2021-09-14 AU AU2021339978A patent/AU2021339978A1/en not_active Abandoned
- 2021-09-14 KR KR1020237012502A patent/KR20240102916A/ko active Pending
- 2021-09-14 JP JP2023516720A patent/JP2023542107A/ja not_active Withdrawn
- 2021-09-14 US US18/044,897 patent/US20230374116A1/en active Pending
- 2021-09-14 EP EP21778541.9A patent/EP4211157A1/en not_active Withdrawn
- 2021-09-14 WO PCT/GB2021/052383 patent/WO2022053839A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023542107A5 (https=) | ||
| CN111848789B (zh) | 抗sars-cov-2病毒s蛋白的单链抗体及其用途 | |
| CN111116748B (zh) | Pd-l1纳米抗体、制备方法及其应用 | |
| JP2022548066A5 (https=) | ||
| CN111961133A (zh) | 一种针对新冠病毒SARS-CoV-2棘突蛋白非RBD区的单克隆抗体及其应用 | |
| CN111778218A (zh) | 噬菌体展示抗体库及基于其淘筛获得的针对新冠病毒SARS-CoV-2的单克隆抗体 | |
| JP2023524573A5 (https=) | ||
| US20210002699A1 (en) | Tim-3 nanobody, a preparation method thereof, and use thereof | |
| WO2023216623A1 (zh) | SARS-CoV-2α、γ、δ和ο突变株骆驼源高亲和力纳米抗体 | |
| CN117567609A (zh) | 一种血红蛋白鲨源纳米抗体及其制备方法和应用 | |
| WO2022037527A1 (zh) | 结合bcma的单可变结构域及抗原结合分子 | |
| CN114539394B (zh) | SARS-CoV-2α突变株和β突变株骆驼源高亲和力纳米抗体 | |
| CN118652334B (zh) | 一种靶向钙粘蛋白17的纳米抗体及其应用 | |
| WO2023125520A1 (zh) | SARS-CoV-2α、β、γ和δ突变株骆驼源高亲和力纳米抗体 | |
| CN119661713A (zh) | 一种能够激活t细胞活性的抗cd3纳米抗体及其制备方法与应用 | |
| CN114539395B (zh) | SARS-CoV-2野生型毒株和α突变株骆驼源高亲和力纳米抗体 | |
| CN114478761A (zh) | 绿色荧光蛋白鲨源纳米抗体、制备方法及其应用 | |
| CN106928358B (zh) | 一种CD105纳米抗体Nb168 | |
| JP7414225B2 (ja) | ＳＡＲＳ－ＣｏＶ－２結合ペプチド | |
| CN118667000A (zh) | 抗hsa单克隆抗体及其应用 | |
| CN111253489A (zh) | 一种tim-3纳米抗体、制备方法及其应用 | |
| CN106928355B (zh) | 一种CD105纳米抗体Nb184 | |
| CN115850457A (zh) | 一种靶向冠状病毒rbd蛋白的抗体 | |
| CN117088972A (zh) | 一种靶向SARS-CoV-2RBD蛋白的鲨源纳米抗体和应用 | |
| CN116693674B (zh) | 一种与SARS和SARS-CoV-2广谱性结合的纳米抗体及其方法与应用 |